维普期刊资源整合服务平台（V6.5）

165篇 您的检索式：作者名="HESKETH PJ"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Proposal for classifying the acute emetogenicity of cancer chemotherapy 显示文摘	Hesketh PJ Kris MG Grunberg SM	1997	Clin Oncol1997，15，1：	1
2	Drug insight:New antiemetics in the manage- ment of chemotherapy-induced nausea and vomiting 显示文摘	Oo TH Hesketh PJ	2005	Nat Clin Pract Oncol2005，2，4：	1
3	Control of chemotherapy - induced emesis显示文摘	Grunberg SM Hesketh PJ	1993	N Engl J Med1993，329，24：	1
4	Pre'~ention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia international antiemetic consensus conference 显示文摘	ROILA F HESKETH PJ HERRSTEDT J	2006	Ann Oncol2006，17，1：	1
5	Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy显示文摘	Warr DG Hesketh PJ Gralla RJ		0，，12：	1
6	Efficacy and tolerability of aprepitant for prevention of chemotherapy induced nausea and vomiting in patient with breast cancer after moderately emetogenic chemotherapy显示文摘	Wart DG Hesketh PJ Gralla RJ	2005	J Clin Oncol2005，23，12：	1
7	Chemotherapy-induced nausea and vomiting显示文摘	HESKETH PJ	2008	N Engl J Med2008，358，23：	1
8	The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational,randomized,double-blind, placebo-controlled trial in patients receiving high-dose cisplatin-- the Aprepitant Protocol 052 Study Group 显示文摘	Hesketh PJ Grunberg SM Gralla RJ	2003	J Clin Oncol2003，21，22：	1
9	Comparative review of 5 - HT3 receptor antagonists in the treatment of acute chemotherapy - induced nausea and vomiting 显示文摘	Hesketh PJ	2000	Cancer Invest2000，18，2：	1
10	Antiemeties: American Society of Clinical Oncology clinical practice guideline update显示文摘	Baseh E Prestrud AA Hesketh PJ	2011	J Clin Oncol2011，29，31：	1
11	Chemotherapy-induced nausea and vomiting 显示文摘	Hesketh PJ	2008	NEngl JMed2008，358，23：	1
12	Southwest oncology group phase II trial ( S0341 ) of erlotinib ( OSI - 774 ) in patients with advanced non - small - cell lung cancer and a performance status of 2 显示文摘	Hesketh PJ Chanksy K Wozniak AJ	2008	J Thorac Oncol2008，3，9：	1
13	Drug treatment of chemotherapy-induced delayed ernesis显示文摘	Tavorath R Hesketh PJ	1996	Orugs1996，52，5：	1
14	Southwest Oncology Group phase Ⅱ trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2显示文摘	Hesketh PJ Chansky K Wozniak AJ	2008	J Thorac Oncol2008，3，9：	1
15	American Society of Clinical Oncology guideline fur antiemetics in oncology: update 2006 显示文摘	American Society of Clinical Oncology Kris MG Hesketh PJ	2006	J Clin Oncol2006，24，18：	1
16	American society of clinical oncology guideline for antiemetics in oncology: update 2006显示文摘	Kris MG hesketh PJ Somerfield MR	2006	J Clin Oncol2006，24，18：	1
17	Paclitaxel and concurrent radiation for gastric cancer显示文摘	Safran H Wanebo HJ Hesketh PJ	2000	Int J Radiat Oncol Biol Phys2000，46，4：	1
18	Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting显示文摘	Hesketh PJ	2000	Cancer Invest2000，18，2：	1
19	American Society of Clinical Oncology guideline for antiemetics in oncology:update 2006显示文摘	Kris MG Hesketh PJ Somerfield MR	2006	J Clin Oncol2006，24，33：	1
20	Efficacy and tolerability of aprepitant for the prevention of chemotherapy- induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy显示文摘	Warr DG Hesketh PJ Gralla RJ	2005	J Clin Oncol2005，23，12：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示